SCHEMBL7463863

SCHEMBL7463863

CC(C)Cc1cc(F)ccc1S(=O)(=O)NC[C@@H](O)[C@H](Cc1ccc(F)cc1)N(Cc1ccccc1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ OPRK1 P41145 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ BACE1 P56817 2/20 0.36
▸ BACE2 Q9Y5Z0 2/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ DPP9 Q86TI2 1/20 0.36
▸ DPP7 Q9UHL4 1/20 0.36
▸ LIMK2 P53671 1/20 0.36
▸ F2 P00734 1/20 0.35
▸ NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461055 0.98 SMN1; SMN2 (0.40) KMT2ASMN1; SMN2CYP3A4CYP2C19OPRK1
SCHEMBL8795319 0.92 SMN1; SMN2 (0.38) KMT2ASMN1; SMN2CYP3A4CYP2C19MEN1
SCHEMBL8796414 0.92 ALDH1A1 (0.38) KMT2ASMN1; SMN2CYP3A4CYP2C19OPRK1
SCHEMBL7461153 0.88 F2 (0.38) KMT2AOPRK1CA12CA7CA9
SCHEMBL7464516 0.87 PSMB5 (0.39) KMT2AOPRK1MEN1F2
SCHEMBL6708356 0.87 MEN1 (0.41) KMT2AOPRK1CA12CA7CA9
SCHEMBL7460738 0.86 ALDH1A1 (0.41) SMN1; SMN2OPRK1BACE1LIMK2F2
SCHEMBL6708363 0.85 ITGA4 (0.40) KMT2ASMN1; SMN2CYP3A4CYP2C19OPRK1
SCHEMBL6762938 0.82 MEN1 (0.39) KMT2AOPRK1CA12CA7CA9
SCHEMBL8795656 0.81 LMNA (0.38) KMT2AMEN1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0810209-A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1997-12-03 — — EP claimed
EP-0810209-B1 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors SEARLE & CO (US) 2002-06-05 — — EP disclosed
EP-0810209-A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1997-12-03 — — EP disclosed
Send feedback